Theseus Pharmaceuticals Stock Total Asset
Theseus Pharmaceuticals fundamentals help investors to digest information that contributes to Theseus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Theseus Stock. The fundamental analysis module provides a way to measure Theseus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theseus Pharmaceuticals stock.
Theseus |
Theseus Pharmaceuticals Company Total Asset Analysis
Theseus Pharmaceuticals' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Theseus Pharmaceuticals Total Asset | 222.45 M |
Most of Theseus Pharmaceuticals' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theseus Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Theseus Pharmaceuticals has a Total Asset of 222.45 M. This is 97.04% lower than that of the Biotechnology sector and 88.74% lower than that of the Health Care industry. The total asset for all United States stocks is 99.25% higher than that of the company.
Theseus Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theseus Pharmaceuticals' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics of similar companies.Theseus Pharmaceuticals is currently under evaluation in total asset category among its peers.
Theseus Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | (20.19 M) | |||
| Shares Outstanding | 44.65 M | |||
| Shares Owned By Insiders | 2.55 % | |||
| Shares Owned By Institutions | 93.28 % | |||
| Number Of Shares Shorted | 401.68 K | |||
| Price To Earning | 737.67 X | |||
| Price To Book | 0.81 X | |||
| EBITDA | (66.44 M) | |||
| Net Income | (56.61 M) | |||
| Cash And Equivalents | 212.43 M | |||
| Cash Per Share | 5.55 X | |||
| Total Debt | 3.98 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 27.54 X | |||
| Book Value Per Share | 5.17 X | |||
| Cash Flow From Operations | (49.63 M) | |||
| Short Ratio | 0.82 X | |||
| Earnings Per Share | (1.34) X | |||
| Target Price | 5.25 | |||
| Number Of Employees | 38 | |||
| Beta | 3.98 | |||
| Market Capitalization | 181.28 M | |||
| Total Asset | 222.45 M | |||
| Retained Earnings | (112.19 M) | |||
| Working Capital | 190.99 M | |||
| Current Asset | 223.75 M | |||
| Current Liabilities | 11.28 M | |||
| Z Score | 26.67 | |||
| Net Asset | 222.45 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |